Grolez, G.
Kyheng, M.
Lopes, R.
Moreau, C.
Timmerman, K.
Auger, F.
Kuchcinski, G.
Duhamel, A.
Jissendi-Tchofo, P.
Besson, P.
Laloux, C.
Petrault, M.
Devedjian, J. C.
Pérez, Thierry
Pradat, Pierre François
Defebvre, L.
Bordet, R.
Danel-Brunaud, V.
Devos, D. http://orcid.org/0000-0002-2417-799X
Article History
Received: 12 October 2017
Accepted: 10 January 2018
First Online: 29 January 2018
Competing Interests
: Véronique Danel, Jean Christophe Devedjian Guillaume Grolez, Kelly Timmerman, Maud Petrault, Charlotte Laloux, Renaud Lopes, Grégory Kuchcinski, Florent Auger, Alain Duhamel, Maeva Kyheng, Patrice Jissendi-Tchofo, Pierre François Pradat, Pierre Besson, Guillaume Grolez, Régis Bordet have no disclosures. Caroline Moreau has received various honoraria from pharmaceutical companies for consultancy and lectures on Parkinson’s disease at symposia such as Aguettant, Abbvie, Medtronic, Novartis. Luc Defebvre served on the Scientific Advisory Board for Novartis and Aguettant, and received honoraria from pharmaceutical companies for consultancy and lectures. David Devos served on advisory boards, as a consultant and given lectures for pharmaceutical companies such as Orkyn, Aguettant, Abbvie, Medtronic, Novartis, Teva, UCB, Lundbeck, ApoPharma.